Is it safe to readminister tumor necrosis factor α antagonists following tuberculosis flare?

被引:15
作者
Aslanidis, Spyros [1 ]
Pyrpasopoulou, Athina [1 ]
Dourna, Stella [1 ]
Petidis, Konstantinos [1 ]
机构
[1] Hippokrateion Hosp, Thessaloniki, Greece
来源
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 01期
关键词
D O I
10.1002/art.23210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:327 / 328
页数:2
相关论文
共 8 条
[1]   Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden [J].
Askling, J ;
Fored, CM ;
Brandt, L ;
Baecklund, E ;
Bertilsson, L ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Romanus, V ;
Klareskog, L ;
Feltelius, N .
ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :1986-1992
[2]  
Iliopoulos A, 2006, INT J TUBERC LUNG D, V10, P588
[3]  
Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328
[4]   Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al [J].
Molenaar, ETH ;
Bultink, IEM ;
Dijkmans, BAC ;
Lems, WF .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1334-1336
[5]   Drug therapy - New drugs for rheumatoid arthritis [J].
Olsen, NJ ;
Stein, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2167-2179
[6]   Life and death in the granuloma: immunopathology of tuberculosis [J].
Saunders, Bernadette M. ;
Britton, Warwick J. .
IMMUNOLOGY AND CELL BIOLOGY, 2007, 85 (02) :103-111
[7]  
Sichletidis L, 2006, INT J TUBERC LUNG D, V10, P1127
[8]   Reconsidering adjuvant immunotherapy for tuberculosis [J].
Wallis, RS .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (02) :201-208